4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
RTW Biotech Opportunities Ltd (RTW) operates in the Asset Management industry and is headquartered in New York, United States. Its market capitalization is roughly $832 million. In the fiscal year ended 2025-12-31, RTW reported $251M in revenue and $245M in net income.
RTW Biotech Opportunities Ltd is a venture capital fund. The fund specializes in directly investing and early-stage. The fund specializes in identifying transformative assets with high growth potential across the life sciences, biopharmaceutical and medical technology sectors.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $251M | $39M | $86M | ($36M) |
| Net Income | $245M | $34M | $83M | ($39M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | — | — | — | $0M | ($5M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Assets | $1.1B | $760M | $446M | $402M |
| Total Liabilities | $204M | $127M | $17M | $54M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive RTW viewer.
About TickerBase · Data methodology & sources · Privacy · Terms